Literature DB >> 1933589

Pathogenesis of osteoporosis.

H K Väänänen1.   

Abstract

The final clinical outcome of the osteoporotic process is a fracture, which can occur as a result of minimal trauma or even spontaneously. At present low bone mass is regarded as the main contributor to bone fragility, but possible qualitative changes in the bone matrix must also be considered. Two factors which determine the level of bone mass at any age are the obtained peak bone mass and duration and rate of bone loss. Peak bone mass is achieved during the first three decades of life. Genetic and nutritional factors as well as mechanical stress on the skeleton obviously play crucial roles in determining peak bone mass. Two phases of bone loss--age-related and menopause-related--dictate the final bone mass at old age. Postmenopausal osteoporosis is a particular example of unbalanced bone resorption leading to net bone loss. An increasing number of systemic and local factors have been found to participate in the regulation of bone remodeling.

Entities:  

Mesh:

Year:  1991        PMID: 1933589     DOI: 10.1007/bf02555080

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  28 in total

Review 1.  Clinical review 8: Clinical heterogeneity of involutional osteoporosis: implications for preventive therapy.

Authors:  B L Riggs; L J Melton
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

2.  Identification of androgen receptors in normal human osteoblast-like cells.

Authors:  D S Colvard; E F Eriksen; P E Keeting; E M Wilson; D B Lubahn; F S French; B L Riggs; T C Spelsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 3.  Perspectives: adhesion receptors in bone.

Authors:  M A Horton; J Davies
Journal:  J Bone Miner Res       Date:  1989-12       Impact factor: 6.741

Review 4.  Histomorphometric analysis of bone in metabolic bone disease.

Authors:  E F Eriksen; T Steiniche; L Mosekilde; F Melsen
Journal:  Endocrinol Metab Clin North Am       Date:  1989-12       Impact factor: 4.741

5.  Organization of osteoclast microfilaments during the attachment to bone surface in vitro.

Authors:  P Lakkakorpi; J Tuukkanen; T Hentunen; K Järvelin; K Väänänen
Journal:  J Bone Miner Res       Date:  1989-12       Impact factor: 6.741

6.  Bone mass is low in relatives of osteoporotic patients.

Authors:  R A Evans; G M Marel; E K Lancaster; S Kos; M Evans; S Y Wong
Journal:  Ann Intern Med       Date:  1988-12-01       Impact factor: 25.391

Review 7.  Estrogens and progestins in the management of primary hyperparathyroidism.

Authors:  R Marcus
Journal:  Endocrinol Metab Clin North Am       Date:  1989-09       Impact factor: 4.741

8.  The relative contributions of age and years since menopause to postmenopausal bone loss.

Authors:  B E Nordin; A G Need; B E Chatterton; M Horowitz; H A Morris
Journal:  J Clin Endocrinol Metab       Date:  1990-01       Impact factor: 5.958

9.  Measurement of bone mineral content of the lumbar spine by dual energy x-ray absorptiometry in normal children: correlations with growth parameters.

Authors:  C Glastre; P Braillon; L David; P Cochat; P J Meunier; P D Delmas
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

10.  Persistently elevated parathyroid hormone secretion and action in young women after four weeks of ingesting high phosphorus, low calcium diets.

Authors:  M S Calvo; R Kumar; H Heath
Journal:  J Clin Endocrinol Metab       Date:  1990-05       Impact factor: 5.958

View more
  3 in total

1.  Physical activity and bone mineral density in Italian middle-aged women.

Authors:  E Bidoli; D Schinella; S Franceschi
Journal:  Eur J Epidemiol       Date:  1998-02       Impact factor: 8.082

2.  Artificial neural networks in prediction of bone density among post-menopausal women.

Authors:  M Sadatsafavi; A Moayyeri; A Soltani; B Larijani; M Nouraie; S Akhondzadeh
Journal:  J Endocrinol Invest       Date:  2005-05       Impact factor: 4.256

3.  An Increased Risk of Osteoporosis during Acquired Immunodeficiency Syndrome.

Authors:  N Annapoorna; G Venkateswara Rao; N S Reddy; P Rambabu; K R S Samabasiva Rao
Journal:  Int J Med Sci       Date:  2004-08-05       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.